Pediatric Advisory Committee; Amendment of Notice; Correction, 62581 [E9-28448]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 228 / Monday, November 30, 2009 / Notices
the Committee will make its
recommendation(s) to CMS.
MEDCAC, Centers for Medicare &
Medicaid Services, Office of Clinical
Standards and Quality, Coverage and
Analysis Group, C1–09–06, 7500
Security Boulevard, Baltimore, MD
21244 or contact Ms. Ellis by phone
(410–786–0309) or via e-mail at
Maria.Ellis@cms.hhs.gov.
III. Registration Instructions
CMS’ Coverage and Analysis Group is
coordinating meeting registration. While
there is no registration fee, individuals
must register to attend. You may register
by contacting the person listed in the
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT
I. Background
MEDCAC, formerly known as the
Medicare Coverage Advisory Committee
(MCAC), provides advice and
recommendations to CMS regarding
clinical issues. (For more information
on MCAC, see the December 14, 1998
Federal Register (63 FR 68780)). This
notice announces the January 27, 2010,
public meeting of the Committee.
During this meeting, the Committee will
discuss the sufficiency of currently
available evidence to determine whether
the results of pharmacogenomic testing
affect health outcomes of patients with
cancer when used as a guide for certain
drug treatments. Background
information about this topic, including
panel materials, is available at https://
www.cms.hhs.gov/coverage. We
encourage the participation of
appropriate organizations with expertise
in pharmacogenomics and oncology.
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
II. Meeting Format
This meeting is open to the public.
The Committee will hear oral
presentations from the public for
approximately 45 minutes. The
Committee may limit the number and
duration of oral presentations to the
time available. Your comments should
focus on issues specific to the list of
topics that we have proposed to the
Committee. The list of research topics to
be discussed at the meeting will be
available on the following Web site
prior to the meeting: https://
www.cms.hhs.gov/mcd/
index_list.asp?list_type=mcac. We
require that you declare at the meeting
whether you have any financial
involvement with manufacturers (or
their competitors) of any items or
services being discussed.
The Committee will deliberate openly
on the topics under consideration.
Interested persons may observe the
deliberations, but the Committee will
not hear further comments during this
time except at the request of the
chairperson. The Committee will also
allow a 15-minute unscheduled open
public session for any attendee to
address issues specific to the topics
under consideration. At the conclusion
of the day, the members will vote and
VerDate Nov<24>2008
14:58 Nov 27, 2009
Jkt 220001
section of this notice by the deadline
listed in the DATES section of this notice.
Please provide your full name (as it
appears on your State-issued driver’s
license), address, organization,
telephone, fax number(s), and e-mail
address. You will receive a registration
confirmation with instructions for your
arrival at the CMS complex or you will
be notified the seating capacity has been
reached.
IV. Security, Building, and Parking
Guidelines
This meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. We
recommend that confirmed registrants
arrive reasonably early, but no earlier
than 45 minutes prior to the start of the
meeting, to allow additional time to
clear security. Security measures
include the following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel.
• Inspection of vehicle’s interior and
exterior (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Inspection, via metal detector or
other applicable means of all persons
entering the building. We note that all
items brought into CMS, whether
personal or for the purpose of
presentation or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
presentation or to support a
presentation.
Note: Individuals who are not registered in
advance will not be permitted to enter the
building and will be unable to attend the
meeting. The public may not enter the
building earlier than 45 minutes prior to the
convening of the meeting.
All visitors must be escorted in areas other
than the lower and first floor levels in the
Central Building.
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: November 19, 2009.
Barry M. Straube,
Chief Medical Officer and Director, Office
of Clinical Standards and Quality, Centers
for Medicare & Medicaid Services.
[FR Doc. E9–28457 Filed 11–27–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Pediatric Advisory Committee;
Amendment of Notice; Correction
AGENCY:
Food and Drug Administration,
HHS
ACTION:
Notice; correction.
The Food and Drug Administration
(FDA) is correcting a notice that
appeared in the Federal Register of
November 2, 2009 (74 FR 56652). The
document announced an amendment to
the notice of meeting of the Pediatric
Advisory Committee. This meeting was
announced in the Federal Register of
October 6, 2009 (74 FR 51289). The
document was published with an
inadvertent error. This document
corrects that error.
FOR FURTHER INFORMATION CONTACT:
Joyce A. Strong, Office of Policy (HF–
27), Food and Drug Administration,
5600 Fishers Lane, Rockville, MD
20957, 301–827–7010.
In FR Doc.
E9–26262, appearing on page 56652, in
the Federal Register of Monday,
November 2, 2009, the following
correction is made:
1. On page 56652, in the first column,
the heading ‘‘[Docket No. 2009–N–
0664]’’ is corrected to read ‘‘[Docket No.
FDA–2009–N–0664]’’.
SUPPLEMENTARY INFORMATION:
Dated: November 20, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–28448 Filed 11–27–09; 8:45 am]
BILLING CODE 4160–01–S
Authority: 5 U.S.C. App. 2, section 10(a).
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
62581
E:\FR\FM\30NON1.SGM
30NON1
]]>Agencies
[Federal Register Volume 74, Number 228 (Monday, November 30, 2009)]
[Notices]
[Page 62581]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-28448]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0664]
Pediatric Advisory Committee; Amendment of Notice; Correction
AGENCY: Food and Drug Administration, HHS
ACTION: Notice; correction.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is correcting a notice that
appeared in the Federal Register of November 2, 2009 (74 FR 56652). The
document announced an amendment to the notice of meeting of the
Pediatric Advisory Committee. This meeting was announced in the Federal
Register of October 6, 2009 (74 FR 51289). The document was published
with an inadvertent error. This document corrects that error.
FOR FURTHER INFORMATION CONTACT: Joyce A. Strong, Office of Policy
(HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD
20957, 301-827-7010.
SUPPLEMENTARY INFORMATION: In FR Doc. E9-26262, appearing on page
56652, in the Federal Register of Monday, November 2, 2009, the
following correction is made:
1. On page 56652, in the first column, the heading ``[Docket No.
2009-N-0664]'' is corrected to read ``[Docket No. FDA-2009-N-0664]''.
Dated: November 20, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-28448 Filed 11-27-09; 8:45 am]
BILLING CODE 4160-01-S
